Gergely’s bill to enhance quality of donated plasma in PA passes House unanimously

HARRISBURG, Dec. 11 – State Rep. Matthew R. Gergely’s bill that would ensure plasma donated throughout Pennsylvania is suitable for subsequent use in health and medical forums passed the state House of Representatives unanimously.

The legislation (H.B. 1795) would require that source plasma specifically, undergoes extensive testing upon donation and before it is ultimately integrated into essential pharmaceuticals. Gergely’s bill, co-sponsored by state Rep. Tim Briggs of Montgomery County, would also allow more focus to be devoted to developing such pharmaceuticals by eliminating a signification portion of subsequent testing conducted in labs during the clinical development phase.

“Having several source plasma centers local to the citizens I represent is a big part of why it’s such a priority for me. Safeguarding healthy and viable plasma will save lives and enhance quality of life throughout the 35th District and the Commonwealth at large,” said Gergely, D-Allegheny. “Thank you to my colleagues on both sides of the aisle for moving this commitment to human welfare a step closer to reality.”

“Plasma is a lifeline for countless individuals battling critical conditions. This proposed legislation aims to optimize this life-saving resource, ensuring its safety while expediting its availability for pharmaceutical use,” Briggs added. “Collaborating on this bill underscores our dedication to advancing innovative medical solutions that save lives and bolster the well-being of Pennsylvanians.”

In 2017 alone, approximately 30 million liters of source plasma were collected in approximately 40 million procedures in the United States, per a work published in the American Journal of Hematology.

The bill now heads to the Senate for consideration.